Picrorhiza kurroa (Kutaki) Royle ex Benth as a hepatoprotective agent--experimental & clinical studies. 1996

A B Vaidya, and D S Antarkar, and J C Doshi, and A D Bhatt, and V Ramesh, and P V Vora, and D Perissond, and A J Baxi, and P M Kale
Ciba Research Centre, Goregaon, Bombay.

Picrorhiza kurroa (Pk), a known hepatoprotective plant, was studied in experimental and clinical situtations. The standardization of active principles--Picroside 1 and 2 was done with High Performance Liquid Chromatography. Picroside 1 ranged from 2.72 to 2.88 mg/capsule and picroside 2 from 5.50 to 6.00 mg/capsule. In the galactosamine-induced liver injury in rats, Pk at a dose of 200 mg/kg p.o. showed a significant reduction (p < 0.05) in liver lipid content, GOT and GPT. In a randomised, double-blind placebo controlled trial in patients diagnosed to have acute viral hepatitis (HBsAg negative), Pk root powder 375 mg three times a day was given for 2 weeks (n = 15) or a matching placebo (n = 18) was given. Difference in values of bilirubin, SGOT and SGPT was significant between placebo and Pk groups. The time in days required for total serum bilirubin to drop to average value of 2.5 mg% was 75.9 days in placebo as against 27.44 days in Pk group. The present study has shown a biological plausability of efficacy of Pk as supported by clinical trial in viral hepatitis, hepatoprotection in animal model and an approach for standardizing extracts based on picroside content.

UI MeSH Term Description Entries
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D008297 Male Males
D008515 Medicine, Ayurvedic The traditional medicine which is based on customs, beliefs, and practices of the Hindu culture. Ayurvedic Medicine,Medicine, Hindu,Siddha Medicine,Hindu Medicine,Medicine, Siddha
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002934 Cinnamates Derivatives of cinnamic acid (the structural formula: phenyl-HC Cinnamate
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D006027 Glycosides Any compound that contains a constituent sugar, in which the hydroxyl group attached to the first carbon is substituted by an alcoholic, phenolic, or other group. They are named specifically for the sugar contained, such as glucoside (glucose), pentoside (pentose), fructoside (fructose), etc. Upon hydrolysis, a sugar and nonsugar component (aglycone) are formed. (From Dorland, 28th ed; From Miall's Dictionary of Chemistry, 5th ed) Glycoside
D006525 Hepatitis, Viral, Human INFLAMMATION of the LIVER in humans due to infection by VIRUSES. There are several significant types of human viral hepatitis with infection caused by enteric-transmission (HEPATITIS A; HEPATITIS E) or blood transfusion (HEPATITIS B; HEPATITIS C; and HEPATITIS D). Viral Hepatitis, Human,Human Viral Hepatitides,Human Viral Hepatitis,Viral Hepatitides, Human

Related Publications

A B Vaidya, and D S Antarkar, and J C Doshi, and A D Bhatt, and V Ramesh, and P V Vora, and D Perissond, and A J Baxi, and P M Kale
August 1970, Experientia,
A B Vaidya, and D S Antarkar, and J C Doshi, and A D Bhatt, and V Ramesh, and P V Vora, and D Perissond, and A J Baxi, and P M Kale
September 1970, The Journal of organic chemistry,
A B Vaidya, and D S Antarkar, and J C Doshi, and A D Bhatt, and V Ramesh, and P V Vora, and D Perissond, and A J Baxi, and P M Kale
May 1988, Plant cell reports,
A B Vaidya, and D S Antarkar, and J C Doshi, and A D Bhatt, and V Ramesh, and P V Vora, and D Perissond, and A J Baxi, and P M Kale
July 2010, Journal of Ayurveda and integrative medicine,
A B Vaidya, and D S Antarkar, and J C Doshi, and A D Bhatt, and V Ramesh, and P V Vora, and D Perissond, and A J Baxi, and P M Kale
January 1989, Indian journal of physiology and pharmacology,
A B Vaidya, and D S Antarkar, and J C Doshi, and A D Bhatt, and V Ramesh, and P V Vora, and D Perissond, and A J Baxi, and P M Kale
January 1988, Indian journal of physiology and pharmacology,
A B Vaidya, and D S Antarkar, and J C Doshi, and A D Bhatt, and V Ramesh, and P V Vora, and D Perissond, and A J Baxi, and P M Kale
September 2009, Current pharmaceutical biotechnology,
A B Vaidya, and D S Antarkar, and J C Doshi, and A D Bhatt, and V Ramesh, and P V Vora, and D Perissond, and A J Baxi, and P M Kale
January 2020, Phytochemistry,
A B Vaidya, and D S Antarkar, and J C Doshi, and A D Bhatt, and V Ramesh, and P V Vora, and D Perissond, and A J Baxi, and P M Kale
January 2015, PloS one,
A B Vaidya, and D S Antarkar, and J C Doshi, and A D Bhatt, and V Ramesh, and P V Vora, and D Perissond, and A J Baxi, and P M Kale
January 2003, Cryo letters,
Copied contents to your clipboard!